Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.27), $0.04 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $69.16 million versus the consensus estimate of $78.87 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.